Monoamine accumulation among sclerotic patients receiving dorsal-column stimulation.
D000690:Amyotrophic Lateral Sclerosis / Q000134:cerebrospinal fluid* / Q000188:drug therapy; D006719:Homovanillic Acid / Q000134:cerebrospinal fluid*; D006801:Humans; D006897:Hydroxyindoleacetic Acid / Q000134:cerebrospinal fluid*; D009103:Multiple Sclerosis / Q000134:cerebrospinal fluid* / Q000188:drug therapy; D010648:Phenylacetates / Q000134:cerebrospinal fluid*; D011339:Probenecid / Q000627:therapeutic use; D013268:Stimulation, Chemical
D010648:Phenylacetates; D006897:Hydroxyindoleacetic Acid; D011339:Probenecid; D006719:Homovanillic Acid